#selective_serotonin_reuptake_inhibitors

  1. Interpersonal sensitivity and response to selective serotonin reuptake inhibitors in patients with acute major depressive disorder
  2. Early symptom non-improvement and aggravation are associated with the treatment response to SSRIs in MDD: A real-world study
  3. Efficacy of selective serotonin reuptake inhibitors in the absence of side effects: A mega-analysis of citalopram and paroxetine in adult depression
  4. Cross-sectional networks of depressive symptoms before and after antidepressant medication treatment
  5. Efficacy of selective serotonin reuptake inhibitors and adverse events: Meta-regression and mediation analysis of placebo-controlled trials
  6. Evidence-based somatic treatment of depression in adults
  7. Review of The emperor's new drugs: Exploding the antidepressant myth
  8. Selective serotonin reuptake inhibitors for unipolar depression: A systematic review of classic long-term randomized controlled trials
  9. Two items on the Hamilton Depression rating scale are effective predictors of remission: Comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine